Deepak Nitrite (DEEPAKNTR) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
13 Apr, 2026Executive summary
Q3 FY26 consolidated revenue grew 3% year-on-year to INR 1,983 crore, with EBITDA up 16% year-on-year to INR 219 crore, reflecting resilience and improved efficiencies amid global competition and pricing pressures.
Nine-month FY26 revenue reached INR 5,820 crore, with EBITDA at INR 658 crore, supported by operational excellence and volume-led growth despite challenging market conditions.
Domestic revenue mix remained strong at 83%, with exports at 17%, highlighting resilience in the domestic market and ongoing global expansion.
Strategic integration and ramp-up of new capacities, including Nitric Acid and hydrogenation plants, completed vertical integration and enhanced raw material security.
Operational agility, disciplined value creation, and strong contributions from the Phenolics segment supported performance.
Financial highlights
Q3 FY26 consolidated revenue: INR 1,983 crore (up 3% YoY); EBITDA: INR 219 crore (up 16% YoY); PAT: INR 100 crore (up 2% YoY); EBITDA margin improved to 11% from 10% YoY.
Nine-month FY26 consolidated revenue: INR 5,820 crore; EBITDA: INR 658 crore; PAT: INR 331 crore.
Q3 PBT: INR 151 crore, including a one-time exceptional provision of INR 12.84 crore under new labor codes.
Finance costs for Q3: INR 11 crore; depreciation and amortization: INR 58 crore, reflecting new asset capitalization.
EPS for Q3 FY26 was INR 7.32, up 2% YoY but down 16% sequentially.
Outlook and guidance
Q4 FY26 expected to show favorable performance, with margin normalization as integration benefits materialize and new products are commercialized.
Cautious optimism for Q4 and Q1, with ongoing global volatility and Chinese overcapacity impacting select products.
Prioritizing new product introductions and geographic expansion, especially in Fluorination, Nitration, Nitrite, and Amines.
Removal of U.S. anti-dumping duty on Sodium Nitrite exports and favorable U.S.-India tariff policy expected to boost export opportunities.
In-house Nitric Acid production and downstream amination to steadily enhance margins.
Latest events from Deepak Nitrite
- Q1 FY25 revenue and profit surged on strong phenolics and expansion progress.DEEPAKNTR
Q1 20252 Feb 2026 - H1 FY25 revenue and profit rose on phenolics strength and major polycarbonate investment.DEEPAKNTR
Q2 202514 Jan 2026 - Q3 FY25 profit and revenue fell, but margin recovery is expected as new projects ramp up.DEEPAKNTR
Q3 202516 Dec 2025 - Revenue and profit fell, but phenolics and expansion projects support future growth.DEEPAKNTR
Q1 25/2623 Nov 2025 - FY25 revenue up 8% YoY; Q4 recovery and expansions set stage for growth in FY26.DEEPAKNTR
Q4 24/2520 Nov 2025 - Sequential margin gains and project commissioning set the stage for growth despite tariff headwinds.DEEPAKNTR
Q2 202614 Nov 2025